Aristotle Atlantic Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-76,498
Closed -$12.6M 90
2025
Q1
$12.6M Sell
76,498
-19,354
-20% -$3.22M 0.43% 54
2024
Q4
$15.6M Sell
95,852
-6,075
-6% -$1.09M 0.49% 52
2024
Q3
$19.9M Buy
101,927
+3,145
+3% +$579K 0.62% 44
2024
Q2
$17.1M Sell
98,782
-13,446
-12% -$2.24M 0.55% 49
2024
Q1
$19M Buy
112,228
+9,360
+9% +$1.75M 0.62% 47
2023
Q4
$20.3M Buy
102,868
+26,430
+35% +$4.68M 0.71% 47
2023
Q3
$13.3M Sell
76,438
-1,732
-2% -$314K 0.53% 56
2023
Q2
$13.5M Buy
78,170
+49,826
+176% +$8.61M 0.51% 56
2023
Q1
$4.72M Buy
+28,344
New +$4.65M 0.24% 70

Other funds holding ZTS

Aristotle Atlantic Partners's ZTS Position: Q2 2025 in Review

Aristotle Atlantic Partners sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 76,498 shares — an estimated $12.6M sold.

Aristotle Atlantic Partners first reported a position in ZTS in Q1 2023 and held it in 9 quarters. The position peaked at $20.3M in Q4 2023. 1,870 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Aristotle Atlantic Partners reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • Aristotle Atlantic Partners sold 76,498 Zoetis shares in Q2 2025, an estimated $12.6M.
  • Aristotle Atlantic Partners first reported a position in Zoetis in Q1 2023 and held it in 9 quarters.
  • Aristotle Atlantic Partners's Zoetis position peaked at $20.3M in Q4 2023.
  • 1,870 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2025, filed 14 Aug 2025.